Advanced germ cell tumors are aggressive and associated with poor prognosis. Pembrolizumab was overall well-tolerated in 12 heavily pretreated patients. Three patients had radiographic stable disease that lasted for 10.
Advanced germ cell tumors are aggressive and associated with poor prognosis. Pembrolizumab was overall well-tolerated in 12 heavily pretreated patients. Three patients had radiographic stable disease that lasted for 10.